Haematology Flashcards

1
Q

How would you define anaemia in adults?

A

Hb < 125 g/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

List causes of anaemia.

A
REDUCED RBC PRODUCTION
Microcytic (MCV < 80), hypochromic -->
- Iron deficiency
- Thalassemia
Normocytic (MCV 80-100), normochromic -->
- Myelofibrosis
- Aplastic anaemia
- Anaemia of chronic disease
Macrocytic (MCV > 100), normochromic -->
- B12 deficiency
- Folate deficiency

INCREASED RBC LOSS
Bleeding–>
- GI, vaginal, internal (e.g. ruptured AAA), trauma
Haemolysis –>
- Membrane protein defect - hereditary spherocytosis
- Enzyme defect - G6PD
- Haemoglobin defect - thalassemia, sickle cell disease
- Immune - rhesus disease of newborn
- Mechanical trauma - Mechanical heart valve; Microangiopathic: DIC, TTP, HUS, PET

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Outline the process of coagulation.

A

Trauma/ bleeding –>
1. ARTERIOLAR VASOCONSTRICTION
2. PRIMARY HAEMOSTATIS = PLATELET PLUG
- Platelets exposed to subendothelium including von Willebrand factor –>
- Platelets adhere to vessel wall (vWF forms bridge between platetlet GP1b and collagen of vessel wall) –>
- Platelets then:
1. change shape
2. altered GP2b/3a - increases affinity for fibrinogen
3. secretion of granule contents - release of ADP, Ca2+, TXA2 etc.
- Causes cycle of platelet activation and aggregation forming a platelet plug
3. SECONDARY HAEMOSTASIS = COAGULATION CASCADE
Extrinsic pathway = trauma to vessel wall –> exposes tissue factor –> joints with 7 –> to activate factor 10
Intrinsic pathway = trauma to blood –> activation of factor 12 –> activation of 11 –> activation of 9 –> activation of 8 –> activation of 10
Common pathway:
Activated 10 –> joints with factor 5 to form prothrombin activator –> causes prothrombin to become thrombin –> thrombin causes fibrinogen to fibrin + factor 13 cross-links fibrin forming a stable clot.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Explain PT -

  • what coagulation pathway/s does it measure?
  • what causes a prolonged PT?

Explain APTT -

  • what coagulation pathway/s does it measure?
  • what causes a prolonged APTT?
A
PT = EXTRINSIC and COMMON pathways
Used to determine INR
Prolonged PT is caused by:
- Warfarin
- NOACs
- Liver failure/ vitamin K deficiency
- Deficiency of clotting factors in extrinsic or common pathways (extrinsic = 7)

SHOULD NOT be affected by heparin.

APTT = INTRINSIC and COMMON pathways. 
Prolonged aPTT is caused by:
- Heparin
- NOACs
- Deficiency of clotting factors in intrinsic or common pathways (intrinsic = 12, 11, 9, 8) - haemophilia A and B

To remember: PET APE (AIP)
P(Extrinsic)T
A(Intrinsic)PTT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Outline iron absorption in the GIT.

A

Heme iron from meat –> heme transporter –> enters enterocyte.
Non-Heme iron in ferric form –> converted to ferrous form –> enters enterocyte via DMT1

Iron inside enterocyte can:
1. Stay in enterocyte if body’s demand is low –> be lost when enterocyte sloughed off.
2. Enter body if body’s demand is high -
Ferroportin 1 transports ferrous iron across basal membrane –> hephaestin converts iron to Fe2+ –> transported by transferrin to liver or bone marrow.

Body’s iron demand is signalled by hepcidin -
Iron in liver high –> hepcidin produced –> inhibition of ferroportin 1
Iron in liver low –> hepcidin reduced –> ferroportin 1 active

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How would you treat iron deficiency anaemia?

A
  • Address underlying aetiology –> colonoscopy
  • Encourage healthy diet - red meat, leafy green vegetables
  • Oral iron supplementation
  • Consider need for RBC transfusion
    IF THESE INSUFFICIENT - e.g.
  • Oral iron supplements not tolerated
  • GIT problem with absorption of oral iron
  • Oral iron supplements unable to meet iron needs - e.g. ongoing iron losses > oral iron supplement intake
    Then consider parenteral iron infusion.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Explain the types of alpha thalassemia.

Outline the clinical features of each type.

A

There are 4 alpha globin genes –> 4 types of alpha thalassemia.
1 gene affected = silent carrier
2 genes affected = trait
3 genes affected = intermedia aka Hb H disease
4 genes affected = major aka Hydrops fetalis aka Hb Bart’s

Silent carrier = normal bloods, asymptomatic
Trait = mild anaemia, asymptomatic
Hb H disease =
Anaemia (microcytic, hypochromic without iron deficiency): SOB, fatigue, jaundice, failure to thrive
Expansion of bone marrow –> facial dysmorphism (frontal bossing, maxillary hypertrophy)
Extramedullary haematopoiesis –> splenomegaly
Hb Barts = death in utero or newborn

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Explain the pathophysiology of alpha thalassemia.

A

Gene defect (usually deletion) –> Insufficient alpha globin –> relative excess of B globin –> excess B globin aggregate into tetramers (known as Hb H) –> problematic because:

  1. High affinity for O2 –> ineffective at supplying tissues with O2
  2. Beta globin aggregates damage RBC membrane –> haemolysis
  3. Ineffective erythropoiesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Explain the types of beta thalassemia.

Outline the clinical features of each type.

A

Beta globin coded by 2 genes.
1 gene affected (heterozygous) –> B thalassemia minor
2 genes affected (homozygous) –> B thalassemia major

Minor –> mild anaemia, asymptomatic
Major –>
- Symptoms begin at around 6 months when foetal Hb (2 alpha and 2 gamma) transitions to adult Hb (2 alpha and 2 beta)
- Ineffective erythropoiesis –> bone marrow expansion –> facial dysmorphism (frontal bossing, maxillary enlargement –> ‘chipmunk facies’), fragility fracture; extramedullary haematopoiesis –> splenomegaly, hepatomegaly
- Anaemia (microcytic, hypochromic without iron deficiency) –> failure to thrive, fatigue/lethargic, jaundice, pallor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What tests would you order to diagnose thalassemia?

A

FBC
Peripheral blood smear
Iron studies
Electrophoresis of Hb (can quantify types of Hb)
Genetic studies for mutations/deletions of Hb beta and alpha globin genes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is your approach to treating thalassemia?

A

If symptomatic/anaemic (Alpha thalassemia intermedia/ Beta thalassemia minor)

  • Monitor Hb with regular FBC –> Blood transfusions with pRBCs when needed
  • Monitor ferritin –> if iron overloaded use iron chelation therapy
  • Often splenectomy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

List DDX for thrombocytopenia.

A

BONE MARROW DISORDER

  • Myelodysplastic syndromes
  • Acute leukaemia
  • Aplastic anaemia

THROMBOTIC MICROANGIOPATHY

  • TTP - thrombotic thrombocytopenic purpura
  • HUS - haemolytic uremic syndrome

IMMUNE-MEDIATED

  • ITP - Immune thrombocytopenia
  • Secondary to infection: EBV, mumps, varicella, hep C, sepsis (DIC)

MEDICATIONS/ TOXINS

  • Iatrogenic: heparin, chemotherapy/radiation (bone marrow suppression)
  • Alcohol (direct toxicity to bone marrow)

OTHER MEDICAL CONDITION
Chronic liver disease –> portal htn –> splenomegaly
Preeclampsia - HELLP syndrome
Rheumatic disease - e.g. SLE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Briefly outline the pathophysiology and clinical features of the following platelet conditions:
ITP - immune thrombocytopenia
TTP - thrombotic thrombocytopenic purpura
HUS - haemolytic uremic syndrome

A

ITP - immune thrombocytopenia

  • antibody-mediated destruction of platelets
  • normal RBCs and WBCs
  • otherwise asymptomatic
TTP and HUS are primary thrombotic microangiopathies. 
These disorders have a classic pentad:
1. Haemolytic anaemia
2. Thrombocytopenia
3. Fever
4. Renal abnormalities
5. Neurological abnormalities

TTP - thrombotic thrombocytopenic purpura

  • caused by deficiency of ADAMTS13 (protease that cleaves vWF –> deficiency causes formation of platelet microthrombi)
  • kidney minimally affected
  • tx: plasma exchange transfusion (plasmapheresis) with FFP

HUS - haemolytic uremic syndrome

  • caused by Shiga toxin (E coli O157:H7) –> toxins cross GI barrier and enter blood stream –> cause microthrombi (activation of platelets, increased fibrin formation)
    tx: plasma exchange transfusion + antibiotics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What sites are affected by bleeding with (1) platelet disorders, (2) clotting factor disorders?

A
Platelet disorder -->
- Mucosal bleeding: mouth, nose, urinary, GI etc.
- Petechiae
- Purpura 
Clotting factor disorder -->
- Muscles
- Joints
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

HAEMOPHILIA A AND B
What causes haemophilia A and B?
What are the clinical features?
What labs would you order & expected findings?

A

Haemophilia A = inherited deficiency of factor 8; X-linked recessive, 1 in 5000 male births
Haemophilia B = inherited deficiency of factor 9; X-linked recessive, 1 in 20 000 male births.

Features:

  • Bleeding at birth - e.g. cephalohematoma, from heel prick testing
  • Bleeding in childhood - major bruising, bleeding into joints and muscles
  • Family history of haemophilia/ bleeding

Lab findings: FBC, coags

  • Prolonged APTT
  • Factor 8 or 9 level reduced
  • Genetic testing - of patient and family (determine carriers)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Von Willebrand Disease

  • Pattern of inheritance?
  • Typical presentation and clinical features?
  • Typical lab findings?
A
  • Most common inherited bleeding disorder: 1% of population
  • Mostly autosomal dominant; males = females
  • Symptom onset at any age
  • Can present as:
  • – Usually mild/moderate mucocutaneous bleeding —> e.g. epistaxis, easy bruising
  • – Can be severe
  • Lab findings:
  • – Usually NORMAL FBC and COAGS
  • – Confirm dx with VWF antigen (quantitative measurement) or VWF activity (functional assay) testing
17
Q

What are the causes of polycythaemia?

A
PRIMARY:
Polycythaemia vera
SECONDARY:
Smoking
Hypoxemia
Excess EPO - e.g. RCC, polycystic kidney disease